XML 101 R92.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2022
Segment Reporting Information [Line Items]          
Total Consolidated Revenue $ 363,302 $ 371,198 $ 717,861 $ 660,268  
Total consolidated adjusted operating income 79,507 70,234 144,608 106,671  
Restructuring expense (1,363) (3,387) (16,428) (6,481)  
Business acquisition and integration expense (15,941) (9,060) (24,356) (35,613)  
Total consolidated operating income (loss) 46,027 24,734 69,120 2,671  
Interest Expense 15,589 25,929 33,349 73,322  
Other (expense) income, net (2,574) 861 (1,007) 1,739  
Total consolidated income (loss) from continuing operations before income taxes 27,864 (334) 34,764 (68,912)  
Total Consolidated Assets 2,843,038 3,659,773 2,843,038 3,659,773 $ 3,029,175
Total Consolidated capital expenditures 4,196 8,081 9,747 14,772  
Total consolidated depreciation expense 10,656 11,631 21,461 22,130  
Total consolidated intangible asset amortization expense 16,176 30,699 34,704 47,150  
Chamberlain          
Segment Reporting Information [Line Items]          
Total Consolidated Revenue 141,396 139,121 276,801 274,760  
Total consolidated adjusted operating income 33,229 25,791 60,231 46,646  
Total Consolidated capital expenditures 1,492 2,969 2,918 6,614  
Total consolidated depreciation expense 4,099 4,726 8,580 9,310  
Walden University          
Segment Reporting Information [Line Items]          
Total Consolidated Revenue 131,940 140,627 262,841 209,244  
Total consolidated adjusted operating income 29,012 32,401 52,403 43,413  
Total Consolidated capital expenditures 268 2,748 1,093 2,932  
Total consolidated depreciation expense 2,269 2,516 4,864 4,228  
Total consolidated intangible asset amortization expense 16,176 30,699 34,704 47,150  
Medical and Veterinary          
Segment Reporting Information [Line Items]          
Total Consolidated Revenue 89,966 91,450 178,219 176,264  
Total consolidated adjusted operating income 23,017 19,706 40,371 35,371  
Restructuring expense (87) (188) (6,913) (188)  
Total Consolidated capital expenditures 342 504 915 1,759  
Total consolidated depreciation expense 3,031 3,645 6,136 7,100  
Home Office and Other          
Segment Reporting Information [Line Items]          
Total consolidated adjusted operating income (5,751) (7,664) (8,397) (18,759)  
Restructuring expense (1,235) (1,073) (5,576) (4,167)  
Total Consolidated capital expenditures 2,094 1,860 4,821 3,467  
Total consolidated depreciation expense 1,257 744 1,881 1,492  
Segment Reconciling Items          
Segment Reporting Information [Line Items]          
Deferred revenue adjustment 0 (2,354) 0 (8,561)  
CEO transition costs 0 0 0 (6,195)  
Restructuring expense (1,363) (3,387) (16,428) (6,481)  
Business acquisition and integration expense (15,941) (9,060) (24,356) (35,613)  
Total consolidated intangible asset amortization expense $ 16,176 $ 30,699 $ 34,704 $ 47,150